'species Agnostic' Screening of Lipid Nanoparticles Could Accelerate the Development of Cutting Edge Therapies
| Date | 21st, Feb 2022 |
|---|---|
| Source | AZoNano - Nanotechnology Websites |
DESCRIPTION
James Dahlman and Phil Santangelo are helping to define an evolving era in medicine, one in which messenger ribonucleic acid -; mRNA -; can be delivered directly to cells to fight...